Β-Carotene

β-Carotene (beta-carotene) is an organic, strongly colored red-orange pigment abundant in fungi,^[7] plants, and fruits. It is a member of the carotenes, which are terpenoids (isoprenoids), synthesized biochemically from eight isoprene units and thus having 40 carbons.

Not to be confused with beta-keratin.

β-Carotene

Skeletal formula
Ball-and-stick model[1][2]
Space-filling model[1][2]
Names
IUPAC name β,β-Carotene
Systematic IUPAC name 1,1′-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl]bis(2,6,6-trimethylcyclohex-1-ene)
Other names Betacarotene (INN), β-Carotene,[3] Food Orange 5, Provitamin A
Identifiers
CAS Number	7235-40-7 Y
3D model (JSmol)	Interactive image
3DMet	B00389
Beilstein Reference	1917416
ChEBI	CHEBI:17579 Y
ChEMBL	ChEMBL1293 Y
ChemSpider	4444129 Y
ECHA InfoCard	100.027.851
EC Number	230-636-6
E number	E160a (colours)
KEGG	C02094
PubChem CID	5280489
UNII	01YAE03M7J Y
CompTox Dashboard (EPA)	DTXSID3020253
InChI InChI=1S/C40H56/c1-31(19-13-21-33(3)25-27-37-35(5)23-15-29-39(37,7)8) 17-11-12-18-32(2)20-14-22-34(4)26-28-38-36(6)24-16-30-40(38,9) 10/h11-14,17-22,25-28H,15-16,23-24,29-30H2,1-10H3 N Key: OENHQHLEOONYIE-UHFFFAOYSA-N N
SMILES CC2(C)CCCC(\C)=C2\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(/C)CCCC1(C)C
Properties
Chemical formula	C40H56
Molar mass	536.888 g·mol−1
Appearance	Dark orange crystals
Density	1.00 g/cm3[4]
Melting point	183 °C (361 °F; 456 K)[4] decomposes[5]
Boiling point	654.7 °C (1,210.5 °F; 927.9 K) at 760 mmHg (101324 Pa)
Solubility in water	Insoluble
Solubility	Soluble in CS2, benzene, CHCl3, ethanol Insoluble in glycerin
Solubility in dichloromethane	4.51 g/kg (20 °C)[6] = 5.98 g/L (given BCM density of 1.3266 g/cm3 at 20°C)
Solubility in hexane	0.1 g/L
log P	14.764
Vapor pressure	2.71·10−16 mmHg
Refractive index (nD)	1.565
Pharmacology
ATC code	A11CA02 (WHO) D02BB01 (WHO)
Hazards
GHS labelling:
Pictograms
Signal word	Warning
Hazard statements	H315, H319, H412
Precautionary statements	P264, P273, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, P362, P501
NFPA 704 (fire diamond)	0 1 0
Flash point	103 °C (217 °F; 376 K)[5]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is YN ?) Infobox references

Dietary β-carotene is a provitamin A compound, converting in the body to retinol (vitamin A).^[8] In foods, it has rich content in carrots, pumpkin, spinach, and sweet potato.^[8] It is used as a dietary supplement and may be prescribed to treat erythropoietic protoporphyria, an inherited condition of sunlight sensitivity.^[9]

β-carotene is the most common carotenoid in plants.^[8] When used as a food coloring, it has the E number E160a.^[10]: 119 The structure was deduced in 1930.^[11]

Isolation of β-carotene from fruits abundant in carotenoids is commonly done using column chromatography. It is industrially extracted from richer sources such as the algae Dunaliella salina.^[12] The separation of β-carotene from the mixture of other carotenoids is based on the polarity of a compound. β-Carotene is a non-polar compound, so it is separated with a non-polar solvent such as hexane.^[13] Being highly conjugated, it is deeply colored, and as a hydrocarbon lacking functional groups, it is lipophilic.

Provitamin A activity

Plant carotenoids are the primary dietary source of provitamin A worldwide, with β-carotene as the best-known provitamin A carotenoid.^[8] Others include α-carotene and β-cryptoxanthin.^[8] Carotenoid absorption is restricted to the duodenum of the small intestine. One molecule of β-carotene can be cleaved by the intestinal enzyme β,β-carotene 15,15'-monooxygenase into two molecules of vitamin A.^[8][14][15]

Absorption, metabolism and excretion

As part of the digestive process, food-sourced carotenoids must be separated from plant cells and incorporated into lipid-containing micelles to be bioaccessible to intestinal enterocytes.^[8] If already extracted (or synthetic) and then presented in an oil-filled dietary supplement capsule, there is greater bioavailability compared to that from foods.^[16]

At the enterocyte cell wall, β-carotene is taken up by the membrane transporter protein scavenger receptor class B, type 1 (SCARB1). Absorbed β-carotene is then either incorporated as such into chylomicrons or first converted to retinal and then retinol, bound to retinol binding protein 2, before being incorporated into chylomicrons.^[8] The conversion process consists of one molecule of β-carotene cleaved by the enzyme beta-carotene 15,15'-dioxygenase, which is encoded by the BCO1 gene, into two molecules of retinal.^[8] When plasma retinol is in the normal range the gene expression for SCARB1 and BCO1 are suppressed, creating a feedback loop that suppresses β-carotene absorption and conversion.^[16]

The majority of chylomicrons are taken up by the liver, then secreted into the blood repackaged into low density lipoproteins (LDLs).^[8] From these circulating lipoproteins and the chylomicrons that bypassed the liver, β-carotene is taken into cells via receptor SCARB1. Human tissues differ in expression of SCARB1, and hence β-carotene content. Examples expressed as ng/g, wet weight: liver=479, lung=226, prostate=163 and skin=26.^[16]

Once taken up by peripheral tissue cells, the major usage of absorbed β-carotene is as a precursor to retinal via symmetric cleavage by the enzyme beta-carotene 15,15'-dioxygenase, which is encoded by the BCO1 gene.^[8] A lesser amount is metabolized by the mitochondrial enzyme beta-carotene 9',10'-dioxygenase, which is encoded by the BCO2 gene. The products of this asymmetric cleavage are two beta-ionone molecules and rosafluene. BCO2 appears to be involved in preventing excessive accumulation of carotenoids; a BCO2 defect in chickens results in yellow skin color due to accumulation in subcutaneous fat.^[17][18]

Conversion factors

For counting dietary vitamin A intake, β-carotene may be converted either using the newer retinol activity equivalents (RAE) or the older international unit (IU).^[8]

Retinol activity equivalents (RAEs)

Since 2001, the US Institute of Medicine uses retinol activity equivalents (RAE) for their Dietary Reference Intakes, defined as follows:^[8][19]

• 1 μg RAE = 1 μg retinol from food or supplements
• 1 μg RAE = 2 μg all-trans-β-carotene from supplements
• 1 μg RAE = 12 μg of all-trans-β-carotene from food
• 1 μg RAE = 24 μg α-carotene or β-cryptoxanthin from food

RAE takes into account carotenoids' variable absorption and conversion to vitamin A by humans better than and replaces the older retinol equivalent (RE) (1 μg RE = 1 μg retinol, 6 μg β-carotene, or 12 μg α-carotene or β-cryptoxanthin).^[19] RE was developed 1967 by the United Nations/World Health Organization Food and Agriculture Organization (FAO/WHO).^[20]

International Units

Another older unit of vitamin A activity is the international unit (IU).^[8] Like retinol equivalent, the international unit does not take into account carotenoid variable absorption and conversion to vitamin A by humans, as well as the more modern retinol activity equivalent. Unfortunately, food and supplement labels still generally use IU, but IU can be converted to the more useful retinol activity equivalent as follows:^[19]

• 1 μg RAE = 3.33 IU retinol
• 1 IU retinol = 0.3 μg RAE
• 1 IU β-carotene from supplements = 0.3 μg RAE
• 1 IU β-carotene from food = 0.05 μg RAE
• 1 IU α-carotene or β-cryptoxanthin from food = 0.025 μg RAE1

Dietary sources

The average daily intake of β-carotene is in the range 2–7 mg, as estimated from a pooled analysis of 500,000 women living in the US, Canada, and some European countries.^[21] Beta-carotene is found in many foods and is sold as a dietary supplement.^[8] β-Carotene contributes to the orange color of many different fruits and vegetables. Vietnamese gac (Momordica cochinchinensis Spreng.) and crude palm oil are particularly rich sources, as are yellow and orange fruits, such as cantaloupe, mangoes, pumpkin, and papayas, and orange root vegetables such as carrots and sweet potatoes.^[8]

The color of β-carotene is masked by chlorophyll in green leaf vegetables such as spinach, kale, sweet potato leaves, and sweet gourd leaves.^[8][22]

The U.S. Department of Agriculture lists foods high in β-carotene content:^[23]

Food	Beta-carotene Milligrams per 100 g
Sweet potato, skinned, boiled	9.4
Carrot juice	9.3
Carrots, raw or boiled	9.2
Kale, boiled	8.8
Pumpkin, canned	6.9
Spinach, canned	5.9

No dietary requirement

Government and non-government organizations have not set a dietary requirement for β-carotene.^[16]

Side effects

Excess β-carotene is predominantly stored in the fat tissues of the body.^[8] The most common side effect of excessive β-carotene consumption is carotenodermia, a physically harmless condition that presents as a conspicuous orange skin tint arising from deposition of the carotenoid in the outermost layer of the epidermis.^{[8][9][16][24]}

Carotenosis

Carotenoderma, also referred to as carotenemia, is a benign and reversible medical condition where an excess of dietary carotenoids results in orange discoloration of the outermost skin layer.^[8] It is associated with a high blood β-carotene value. This can occur after a month or two of consumption of beta-carotene rich foods, such as carrots, carrot juice, tangerine juice, mangos, or in Africa, red palm oil. β-carotene dietary supplements can have the same effect. The discoloration extends to palms and soles of feet, but not to the white of the eye, which helps distinguish the condition from jaundice. Carotenodermia is reversible upon cessation of excessive intake.^[25] Consumption of greater than 30 mg/day for a prolonged period has been confirmed as leading to carotenemia.^[16][26]

No risk for hypervitaminosis A

At the enterocyte cell wall, β-carotene is taken up by the membrane transporter protein scavenger receptor class B, type 1 (SCARB1). Absorbed β-carotene is then either incorporated as such into chylomicrons or first converted to retinal and then retinol, bound to retinol binding protein 2, before being incorporated into chylomicrons. The conversion process consists of one molecule of β-carotene cleaved by the enzyme beta-carotene 15,15'-dioxygenase, which is encoded by the BCO1 gene, into two molecules of retinal. When plasma retinol is in the normal range the gene expression for SCARB1 and BCO1 are suppressed, creating a feedback loop that suppresses absorption and conversion. Because of these two mechanisms, high intake will not lead to hypervitaminosis A.^[16]

Drug interactions

β-Carotene can interact with medication used for lowering cholesterol.^[8] Taking them together can lower the effectiveness of these medications and is considered only a moderate interaction.^[8] Bile acid sequestrants and proton-pump inhibitors can decrease absorption of β-carotene.^[27] Consuming alcohol with β-carotene can decrease its ability to convert to retinol and could possibly result in hepatotoxicity.^[28]

β-Carotene and lung cancer in smokers

Chronic high doses of β-carotene supplementation increases the probability of lung cancer in smokers^[8][29] while its natural vitamer, retinol, increases lung cancer in smokers and nonsmokers. The effect is specific to supplementation dose as no lung damage has been detected in those who are exposed to cigarette smoke and who ingest a physiological dose of β-carotene (6 mg), in contrast to high pharmacological dose (30 mg).^[8][30].

Increases in lung cancer have been attributed to the tendency of β-carotene to oxidize,^[31] yet based on the pharmacokinetics of β-carotene absorption and transport through the intestine and the lack of specific β-carotene transporters, it is unlikely that β-carotene reaches the lung of smokers in sufficient quantities^[32]. Additional research is required to understand the link between the increased risk of cancer and all-cause mortality following β-carotene supplementation.

Additionally, supplemental, high-dose β-carotene may increase the risk of prostate cancer, intracerebral hemorrhage, and cardiovascular and total mortality irrespective of smoking status.^[8][9]

Industrial sources

β-carotene is industrially made either by total synthesis (see Retinol § Industrial synthesis) or by extraction from biological sources such as vegetables, microalgae (especially Dunaliella salina), and genetically-engineered microbes. The synthetic path is low-cost and high-yield.^[33]

Research

Medical authorities generally recommend obtaining beta-carotene from food rather than dietary supplements.^[8] A 2013 meta-analysis of randomized controlled trials concluded that high-dosage (≥9.6 mg/day) beta-carotene supplementation is associated with a 6% increase in the risk of all-cause mortality, while low-dosage (<9.6 mg/day) supplementation does not have a significant effect on mortality.^[34] Research is insufficient to determine whether a minimum level of beta-carotene consumption is necessary for human health and to identify what problems might arise from insufficient beta-carotene intake.^[35] However, a 2018 meta-analysis mostly of prospective cohort studies found that both dietary and circulating beta-carotene are associated with a lower risk of all-cause mortality. The highest circulating beta-carotene category, compared to the lowest, correlated with a 37% reduction in the risk of all-cause mortality, while the highest dietary beta-carotene intake category, compared to the lowest, was linked to an 18% decrease in the risk of all-cause mortality.^[36]

Macular degeneration

Main article: Macular degeneration

Age-related macular degeneration (AMD) represents the leading cause of irreversible blindness in elderly people. AMD is an oxidative stress, retinal disease that affects the macula, causing progressive loss of central vision.^[37] β-carotene content is confirmed in human retinal pigment epithelium.^[16] Reviews reported mixed results for observational studies, with some reporting that diets higher in β-carotene correlated with a decreased risk of AMD whereas other studies reporting no benefits.^[38] Reviews reported that for intervention trials using only β-carotene, there was no change to risk of developing AMD.^[8][38][39]

Cancer

A meta-analysis concluded that supplementation with β-carotene does not appear to decrease the risk of cancer overall, nor specific cancers including: pancreatic, colorectal, prostate, breast, melanoma, or skin cancer generally.^[8][40] High levels of β-carotene may increase the risk of lung cancer in current and former smokers.^[8][41] Results are not clear for thyroid cancer.^[42]

Cataract

A Cochrane review looked at supplementation of β-carotene, vitamin C, and vitamin E, independently and combined, on people to examine differences in risk of cataract, cataract extraction, progression of cataract, and slowing the loss of visual acuity. These studies found no evidence of any protective effects afforded by β-carotene supplementation on preventing and slowing age-related cataract.^[43] A second meta-analysis compiled data from studies that measured diet-derived serum beta-carotene and reported a not statistically significant 10% decrease in cataract risk.^[44]

Erythropoietic protoporphyria

High doses of β-carotene (up to 180 mg per day) may be used as a treatment for erythropoietic protoporphyria, a rare inherited disorder of sunlight sensitivity, without toxic effects.^[8][9]

Food drying

Foods rich in carotenoid dyes show discoloration upon drying. This is due to thermal degradation of carotenoids, possibly via isomerization and oxidation reactions.^[45]

See also

• Sunless tanning with beta-carotene
• Vitamin A
• Retinol
• Carotenoids

References

1. Hursthouse MB, Nathani SC, Moss GP (2004). "CSD Entry: CARTEN02". Cambridge Structural Database: Access Structures. Cambridge Crystallographic Data Centre. doi:10.5517/cc8j3mh. Retrieved 9 July 2022.
2. Senge MO, Hope H, Smith KM (1992). "Structure and Conformation of Photosynthetic Pigments and Related Compounds 3. Crystal Structure of β-Carotene". Z. Naturforsch. C. 47 (5–6): 474–476. doi:10.1515/znc-1992-0623. S2CID 100905826.
3. "SciFinder – CAS Registry Number 7235-40-7". Retrieved 21 October 2009.
4. Haynes, William M., ed. (2011). CRC Handbook of Chemistry and Physics (92nd ed.). CRC Press. p. 3.94. ISBN 978-1439855119.
5. Sigma-Aldrich Co., β-Carotene. Retrieved on 27 May 2014.
6. "Beta-carotene". PubChem, US National Library of Medicine. 27 January 2024. Retrieved 31 January 2024.
7. Lee SC, Ristaino JB, Heitman J (13 December 2012). "Parallels in Intercellular Communication in Oomycete and Fungal Pathogens of Plants and Humans". PLOS Pathogens. 8 (12): e1003028. doi:10.1371/journal.ppat.1003028. PMC 3521652. PMID 23271965.
8. "α-Carotene, β-Carotene, β-Cryptoxanthin, Lycopene, Lutein, and Zeaxanthin". Micronutrient Information Center, Linus Pauling Institute, Oregon State University, Corvallis. October 2023. Retrieved 31 January 2024.
9. "Beta-carotene". MedlinePlus, National Library of Medicine, US National Institutes of Health. 27 January 2023. Retrieved 31 January 2024.
10. Milne, George W. A. (2005). Gardner's commercially important chemicals: synonyms, trade names, and properties. New York: Wiley-Interscience. ISBN 978-0-471-73518-2.
11. Karrer P, Helfenstein A, Wehrli H (1930). "Pflanzenfarbstoffe XXV. Über die Konstitution des Lycopins und Carotins". Helvetica Chimica Acta. 13 (5): 1084–1099. doi:10.1002/hlca.19300130532.
12. States4439629 United States expired 4439629, Rüegg, Rudolf, "Extraction Process for Beta-Carotene", published 27 March 1984, assigned to Hoffmann-La Roche Inc.
13. Mercadante AZ, Steck A, Pfander H (January 1999). "Carotenoids from guava (Psidium guajava l.): isolation and structure elucidation". Journal of Agricultural and Food Chemistry. 47 (1): 145–51. doi:10.1021/jf980405r. PMID 10563863.
14. Biesalski HK, Chichili GR, Frank J, von Lintig J, Nohr D (2007). Conversion of β-carotene to retinal pigment. Vitamins & Hormones. Vol. 75. pp. 117–30. doi:10.1016/S0083-6729(06)75005-1. ISBN 978-0-12-709875-3. PMID 17368314.
15. Eroglu A, Harrison EH (July 2013). "Carotenoid metabolism in mammals, including man: formation, occurrence, and function of apocarotenoids". J Lipid Res. 54 (7): 1719–30. doi:10.1194/jlr.R039537. PMC 3679377. PMID 23667178.
16. von Lintig J (2020). "Carotenoids". In BP Marriott, DF Birt, VA Stallings, AA Yates (eds.). Present Knowledge in Nutrition, Eleventh Edition. London, United Kingdom: Academic Press (Elsevier). pp. 531–49. ISBN 978-0-323-66162-1.
17. Babino D, Palczewski G, Widjaja-Adhi MA, Kiser PD, Golczak M, von Lintig J (October 2015). "Characterization of the Role of β-Carotene 9,10-Dioxygenase in Macular Pigment Metabolism". J Biol Chem. 290 (41): 24844–57. doi:10.1074/jbc.M115.668822. PMC 4598995. PMID 26307071.
18. Wu L, Guo X, Wang W, Medeiros DM, Clarke SL, Lucas EA, et al. (November 2016). "Molecular aspects of β, β-carotene-9', 10'-oxygenase 2 in carotenoid metabolism and diseases". Exp Biol Med (Maywood). 241 (17): 1879–1887. doi:10.1177/1535370216657900. PMC 5068469. PMID 27390265.
19. Institute of Medicine (US) Panel on Micronutrients (2001). Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc. (free download): National Academy Press. doi:10.17226/10026. ISBN 978-0-309-07279-3. PMID 25057538. S2CID 44243659.
20. Requirement of Vitamin A, Thiamine, Riboflavin and Niacin. FAO Food and Nutrition Series B. Rome: Food and Agriculture Organization/World Health Organization. 1967.
21. Koushik A, Hunter DJ, Spiegelman D, Anderson KE, Buring JE, Freudenheim JL, et al. (November 2006). "Intake of the major carotenoids and the risk of epithelial ovarian cancer in a pooled analysis of 10 cohort studies". International Journal of Cancer. 119 (9): 2148–54. doi:10.1002/ijc.22076. PMID 16823847. S2CID 22948131.
22. Kidmose U, Edelenbos M, Christensen LP, Hegelund E (October 2005). "Chromatographic determination of changes in pigments in spinach (Spinacia oleracea L.) during processing". Journal of Chromatographic Science. 43 (9): 466–72. doi:10.1093/chromsci/43.9.466. PMID 16212792.
23. "USDA National Nutrient Database for Standard Reference, Release 28" (PDF). 28 October 2015. Retrieved 5 February 2022.
24. Blaner WS (2020). "Vitamin A". In BP Marriott, DF Birt, VA Stallings, AA Yates (eds.). Present Knowledge in Nutrition, Eleventh Edition. London, United Kingdom: Academic Press (Elsevier). pp. 73–92. ISBN 978-0-323-66162-1.
25. Maharshak N, Shapiro J, Trau H (March 2003). "Carotenoderma--a review of the current literature". Int J Dermatol. 42 (3): 178–81. doi:10.1046/j.1365-4362.2003.01657.x. PMID 12653910. S2CID 27934066.
26. Nasser Y, Jamal Z, Albuteaey M (11 August 2021). "Carotenemia". StatPearls. doi:10.1007/s00253-001-0902-7. PMID 30521299. S2CID 22232461.
27. Meschino Health. "Comprehensive Guide to Beta-Carotene". Retrieved 29 May 2012.
28. Leo MA, Lieber CS (June 1999). "Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity". The American Journal of Clinical Nutrition. 69 (6): 1071–85. doi:10.1093/ajcn/69.6.1071. PMID 10357725.
29. Tanvetyanon T, Bepler G (July 2008). "Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands". Cancer. 113 (1): 150–7. doi:10.1002/cncr.23527. PMID 18429004. S2CID 33827601.
30. Russel, R.M. (2002). "Beta-carotene and lung cancer". Pure Appl. Chem. 74 (8): 1461–1467. CiteSeerX 10.1.1.502.6550. doi:10.1351/pac200274081461. S2CID 15046337.
31. Hurst JS, Saini MK, Jin GF, Awasthi YC, van Kuijk FJ (August 2005). "Toxicity of oxidized beta-carotene to cultured human cells". Experimental Eye Research. 81 (2): 239–43. doi:10.1016/j.exer.2005.04.002. PMID 15967438.
32. Babino D, Palczewski G, Widjaja-Adhi MA, Kiser PD, Golczak M, von Lintig J (9 October 2015). "Characterization of the Role of β-Carotene 9,10-Dioxygenase in Macular Pigment Metabolism". The Journal of Biological Chemistry. 290 (41): 24844–24857. doi:10.1074/jbc.M115.668822. ISSN 1083-351X. PMC 4598995. PMID 26307071.
33. Singh RV, Sambyal K (June 2022). "An overview of β-carotene production: Current status and future prospects". Food Bioscience. 47: 101717. doi:10.1016/j.fbio.2022.101717. S2CID 248252973.
34. Bjelakovic G, Nikolova D, Gluud C (2013). "Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?". PLOS ONE. 8 (9): e74558. Bibcode:2013PLoSO...874558B. doi:10.1371/journal.pone.0074558. PMC 3765487. PMID 24040282.
35. Stargrove M (20 December 2007). Herb, nutrient, and drug interactions : clinical implications and therapeutic strategies (1 ed.). Mosby. ISBN 978-0323029643.
36. Jayedi A, Rashidy-Pour A, Parohan M, Zargar MS, Shab-Bidar S (2018). "Dietary Antioxidants, Circulating Antioxidant Concentrations, Total Antioxidant Capacity, and Risk of All-Cause Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Observational Studies". Adv Nutr. 9 (6): 701–716. doi:10.1093/advances/nmy040. PMC 6247336. PMID 30239557.
37. Di Carlo E, Augustin AJ (July 2021). "Prevention of the Onset of Age-Related Macular Degeneration". J Clin Med. 10 (15): 3297. doi:10.3390/jcm10153297. PMC 8348883. PMID 34362080.
38. Gorusupudi A, Nelson K, Bernstein PS (January 2017). "The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration". Adv Nutr. 8 (1): 40–53. doi:10.3945/an.116.013177. PMC 5227975. PMID 28096126.
39. Evans JR, Lawrenson JG (July 2017). "Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration". Cochrane Database Syst Rev. 2017 (7): CD000253. doi:10.1002/14651858.CD000253.pub4. PMC 6483250. PMID 28756617.
40. Druesne-Pecollo N, Latino-Martel P, Norat T, Barrandon E, Bertrais S, Galan P, et al. (July 2010). "Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials". International Journal of Cancer. 127 (1): 172–84. doi:10.1002/ijc.25008. PMID 19876916. S2CID 24850769.
41. Misotti AM, Gnagnarella P (October 2013). "Vitamin supplement consumption and breast cancer risk: a review". ecancermedicalscience. 7: 365. doi:10.3332/ecancer.2013.365. PMC 3805144. PMID 24171049.
42. Zhang LR, Sawka AM, Adams L, Hatfield N, Hung RJ (March 2013). "Vitamin and mineral supplements and thyroid cancer: a systematic review". European Journal of Cancer Prevention. 22 (2): 158–68. doi:10.1097/cej.0b013e32835849b0. PMID 22926510. S2CID 35660646.
43. Mathew MC, Ervin AM, Tao J, Davis RM (June 2012). "Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract". The Cochrane Database of Systematic Reviews. 2012 (6): CD004567. doi:10.1002/14651858.CD004567.pub2. PMC 4410744. PMID 22696344.
44. Cui YH, Jing CX, Pan HW (September 2013). "Association of blood antioxidants and vitamins with risk of age-related cataract: a meta-analysis of observational studies". The American Journal of Clinical Nutrition. 98 (3): 778–86. doi:10.3945/ajcn.112.053835. PMID 23842458.
45. Song J, Wang X, Li D, Liu C (18 December 2017). "Degradation kinetics of carotenoids and visual colour in pumpkin (Cucurbita maxima L.) slices during microwave-vacuum drying". International Journal of Food Properties. 20 (sup1): S632–S643. doi:10.1080/10942912.2017.1306553. ISSN 1094-2912. S2CID 90336692.